Lilly Buys Vaccine Makers
Eli Lilly acquires three vaccine makers for nearly $4 billion, expanding its vaccine portfolio. The move marks a significant push into the vaccine market for the drugmaker.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.